Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Long-Term Investments (2024 - 2025)

Praxis Precision Medicines has reported Long-Term Investments over the past 2 years, most recently at $326.8 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $326.8 million for Q4 2025, up 324.57% from a year ago — trailing twelve months through Dec 2025 was $326.8 million (up 324.57% YoY), and the annual figure for FY2025 was $326.8 million, up 324.57%.
  • Long-Term Investments for Q4 2025 was $326.8 million at Praxis Precision Medicines, up from $122.0 million in the prior quarter.
  • Over the last five years, Long-Term Investments for PRAX hit a ceiling of $326.8 million in Q4 2025 and a floor of $35.9 million in Q1 2024.